Latest Technology News

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Zeotech Limited has secured a strategic MOU with Holcim Australia to advance its AusPozz™ low-carbon concrete product, alongside promising methane reduction results and a newly granted Japanese patent.

Clarity Pharmaceuticals will present compelling data on its 64Cu-SAR-bisPSMA diagnostic agent at two leading oncology conferences, highlighting earlier and more accurate prostate cancer lesion detection than current standards.

Great Dirt Resources Ltd. has confirmed significant manganese mineralisation at its Junior Prospect in NSW, revealing promising high-grade zones and multiple stacked lodes that could substantially boost the project's resource potential.

Hydrix Limited reports back-to-back profitable quarters driven by strong margins and cost efficiencies, underpinned by a robust $40 million sales opportunity pipeline in cardiac and medtech sectors.

XPON Technologies reports a modest 2% increase in martech revenue and a strong cash position for Q2 FY25, while navigating an 8% decline in annualised recurring revenue amid strategic sales recalibration.

Nuix projects solid growth in Annualised Contract Value and revenue for the first half of FY25, despite elongated procurement timelines and increased contract complexity.

Lucapa Diamond Company advances its position in the Lulo Kimberlite Joint Venture, increasing its stake to 51% while accelerating bulk sampling efforts to pinpoint diamond-rich kimberlite targets.

Dropsuite Limited posted a standout quarter with a 37% rise in annual recurring revenue and a 42% jump in paid users, underscoring the strength of its partner ecosystem and product innovation.

IDT Australia reports a near doubling of quarterly revenue to $5.3 million, driven by explosive growth in its Advanced Therapies segment, with first-half revenue expected to jump 82%.

Pureprofile Limited has upgraded its FY25 financial guidance following a robust first half, highlighted by a 22% revenue increase and a 30% surge in Q2, driven by strong international expansion and automation adoption.

IperionX has completed its inaugural end-to-end titanium powder production cycle using its proprietary HAMR process and secured exclusive rights to breakthrough titanium technologies, positioning itself for expanded manufacturing capacity and strong market demand.